GlassScriptPhysician profile
Krishan V Soni
NPI 1639404114
$22,461.17
in general payments reported to CMS, 2019-2025
19 companies · $1,999 in 2025
The $1,999 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $493 · 2021: $449 · 2022: $345 · 2023: $720 · 2024: $7,802 · 2025: $1,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,830 · Consulting Fee: $4,688 · Travel and Lodging: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,830.02 |
| Consulting Fee | $4,687.50 |
| Travel and Lodging | $1,003.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,094.94 | 2019-2025 | General - Therapies, General - Vascular Access, Avvigo Guidance System |
| Medtronic Vascular, INC. | $8,947.73 | 2019 | |
| Cardiovascular Systems INC. | $1,135.19 | 2019-2022 | |
| Abiomed | $712.70 | 2019-2025 | Impella |
| Shockwave Medical, INC | $579.90 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $487.08 | 2019-2025 | Optis, Dragonfly Opstar, Diamondback Coronary |
| Heartflow, INC. | $268.19 | 2021-2025 | Ffrct |
| Amgen INC. | $238.41 | 2019-2023 | Repatha |
| Terumo Medical Corporation | $184.98 | 2023-2025 | Glidesheath Slender, Tr Band, Angio-Seal |
| Asahi Intecc USA, INC. | $181.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.64 | 2025 | |
| Edwards Lifesciences Corporation | $108.15 | 2024-2025 | Sapien 3 Ultra Resilia |
| Teleflex LLC | $95.22 | 2025 | Turnpike, Trapliner |
| Medtronic, INC. | $84.43 | 2021-2024 | Symplicity G3 |
| Philips North America LLC | $73.85 | 2023-2024 | (Bq9) Coronary Ivus, (9266) Elca, (P84) Igt Devices Systems |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $69.01 | 2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.73 | 2022 | |
| Siemens Medical Solutions USA, INC. | $25.77 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishan Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.